Inteum Company
Links
seedsprint
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Transgenic Mice with Constitutively Active M3 Muscarinic Receptor in Islet Beta Cells
Case ID:
TAB-2585
Web Published:
12/6/2022
Q490L point mutation was introduced into the rat M3 muscarinic receptor cDNA to confer persistent, constitutive (ligand-independent) activity. Expression of the M3 receptor mutant was placed under the control of a 650 bp fragment of the rat insulin promoter II (RIP II) to limit expression to the islet beta cell.
Patent Information:
Title
App Type
Country
Serial No.
Patent No.
File Date
Issued Date
Expire Date
Direct Link:
https://canberra-ip.technologypublisher.com/tech/Transgenic_Mice_with_Constit utively_Active_M3_Muscarinic_Receptor_in_Islet_Beta_Cells
Keywords:
Active
Beta
Cells
CONSTITUTIVELY
IDXXXX
ISLET
IXXXXX
M3
Mice
MUSCARINIC
RECEPTOR
TRANSGENIC
Bookmark this page
Download as PDF
For Information, Contact:
Mythreyi Shastri
Technology Development Specialist
NIH Technology Transfer
301-435-0613
shastrim@mail.nih.gov